T&R Biofab Co., Ltd. (KOSDAQ:246710)
South Korea · Delayed Price · Currency is KRW 3,025.00
-45.00 (-1.47%)
Apr 29, 2026, 11:08 AM KST
T&R Biofab Market Cap
T&R Biofab has a market cap or net worth of 146.04 billion as of April 28, 2026. Its market cap has increased by 63.32% in one year.
Market Cap
146.04B
Enterprise Value
167.74B
Revenue
26.97B
Ranking
n/a
PE Ratio
n/a
Stock Price
3,025.00
Market Cap Chart
Since November 28, 2018, T&R Biofab's market cap has increased from 101.48B to 146.04B, an increase of 43.91%. That is a compound annual growth rate of 5.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 150.56B | -16.02% |
| Dec 30, 2025 | 179.28B | 91.93% |
| Dec 30, 2024 | 93.41B | -51.40% |
| Dec 28, 2023 | 192.21B | -20.80% |
| Dec 29, 2022 | 242.68B | -53.25% |
| Dec 30, 2021 | 519.07B | 265.38% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Nov 28, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| InBody Co.,Ltd | 406.81B |
| Bio Plus | 359.40B |
| DRTECH | 150.84B |
| Osang Healthcare Co.,Ltd | 127.51B |
| Ray Co., Ltd. | 123.26B |
| P&S Robotics | 109.49B |
| LabGenomics | 104.01B |
| Sugentech | 89.29B |